Back
Speaker illustration

undefined undefined undefined

Presentations Articles

The expanding role of semaglutide in cardiovascular disease and its the effect on blood pressure

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Hypertension management: drugs

Access
Like
Thumbnail

Semaglutide for the treatment of resistant hypertension

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Secondary and resistant hypertension

Access
Like
Thumbnail

Blood pressure effect of semaglutide in patients with hypertension: an individual patient data analysis of randomised controlled trials

Event: ESC Preventive Cardiology 2024

Topic: Pharmacotherapy

Session: Managing hypertension

Access
Like
Thumbnail

Lipoprotein(a) and referrals to a specialist lipid clinic

Event: ESC Preventive Cardiology 2024

Topic: Lipids

Session: Advances in risk stratification and lipid management

Access
Like
Thumbnail

Restarting statins in a specialist lipid clinic setting

Event: ESC Preventive Cardiology 2023

Topic: Lipid-Lowering Agents

Session: Young Investigators Award - Secondary Prevention and Rehabilitation

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources